Selected research
Industry Research
Hyperthermia Therapy for Cancer Industry Research Report 2026
Market perspective
The global Hyperthermia Therapy for Cancer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hyperthermia Therapy for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hyperthermia Therapy for Cancer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hyperthermia Therapy for Cancer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hyperthermia Therapy for Cancer include Pyrexar Medical, Oncotherm, Andromedic, Yamamoto Vinita, Med-Logix, Thermofield, Celsius42, Dongseo Medicare and ThermaSolutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hyperthermia Therapy for Cancer market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hyperthermia Therapy for Cancer Market by Company
Pyrexar Medical
Oncotherm
Andromedic
Yamamoto Vinita
Med-Logix
Thermofield
Celsius42
Dongseo Medicare
ThermaSolutions
Verthermia
Combat Medical
Hydrosun
RanD Biotech
Shenzhen ET Medical Technology
Jiangsu Nova Medical Equipment
Hyperthermia Therapy for Cancer Segment by Type
Superficial Hyperthermia
Deep Regional Hyperthermia
Hyperthermia Therapy for Cancer Segment by Application
Breast Cancer
Cervical Cancer
Soft Tissue Sarcoma
Melanoma
Others
Hyperthermia Therapy for Cancer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperthermia Therapy for Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyperthermia Therapy for Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperthermia Therapy for Cancer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyperthermia Therapy for Cancer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyperthermia Therapy for Cancer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyperthermia Therapy for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Superficial Hyperthermia
- Deep Regional Hyperthermia
Applications
- Breast Cancer
- Cervical Cancer
- Soft Tissue Sarcoma
- Melanoma
- Others
Companies covered
- Pyrexar Medical
- Oncotherm
- Andromedic
- Yamamoto Vinita
- Med-Logix
- Thermofield
- Celsius42
- Dongseo Medicare
- ThermaSolutions
- Verthermia
- Combat Medical
- Hydrosun
- RanD Biotech
- Shenzhen ET Medical Technology
- Jiangsu Nova Medical Equipment
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hyperthermia Therapy for Cancer Market Size (2021-2032)
- 2.2.2 Global Hyperthermia Therapy for Cancer Sales (2021-2032)
- 2.2.3 Global Hyperthermia Therapy for Cancer Market Average Price (2021-2032)
- 2.3 Hyperthermia Therapy for Cancer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Superficial Hyperthermia
- 2.3.3 Deep Regional Hyperthermia
- 2.4 Hyperthermia Therapy for Cancer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Cervical Cancer
- 2.4.4 Soft Tissue Sarcoma
- 2.4.5 Melanoma
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hyperthermia Therapy for Cancer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hyperthermia Therapy for Cancer Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Hyperthermia Therapy for Cancer Revenue of Manufacturers (2021-2026)
- 3.4 Global Hyperthermia Therapy for Cancer Average Price by Manufacturers (2021-2026)
- 3.5 Global Hyperthermia Therapy for Cancer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hyperthermia Therapy for Cancer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hyperthermia Therapy for Cancer, Product Type & Application
- 3.8 Global Manufacturers of Hyperthermia Therapy for Cancer, Established Date
- 3.9 Global Hyperthermia Therapy for Cancer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pyrexar Medical
- 4.1.1 Pyrexar Medical Company Information
- 4.1.2 Pyrexar Medical Business Overview
- 4.1.3 Pyrexar Medical Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pyrexar Medical Hyperthermia Therapy for Cancer Product Portfolio
- 4.1.5 Pyrexar Medical Recent Developments
- 4.2 Oncotherm
- 4.2.1 Oncotherm Company Information
- 4.2.2 Oncotherm Business Overview
- 4.2.3 Oncotherm Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Oncotherm Hyperthermia Therapy for Cancer Product Portfolio
- 4.2.5 Oncotherm Recent Developments
- 4.3 Andromedic
- 4.3.1 Andromedic Company Information
- 4.3.2 Andromedic Business Overview
- 4.3.3 Andromedic Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Andromedic Hyperthermia Therapy for Cancer Product Portfolio
- 4.3.5 Andromedic Recent Developments
- 4.4 Yamamoto Vinita
- 4.4.1 Yamamoto Vinita Company Information
- 4.4.2 Yamamoto Vinita Business Overview
- 4.4.3 Yamamoto Vinita Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yamamoto Vinita Hyperthermia Therapy for Cancer Product Portfolio
- 4.4.5 Yamamoto Vinita Recent Developments
- 4.5 Med-Logix
- 4.5.1 Med-Logix Company Information
- 4.5.2 Med-Logix Business Overview
- 4.5.3 Med-Logix Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Med-Logix Hyperthermia Therapy for Cancer Product Portfolio
- 4.5.5 Med-Logix Recent Developments
- 4.6 Thermofield
- 4.6.1 Thermofield Company Information
- 4.6.2 Thermofield Business Overview
- 4.6.3 Thermofield Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thermofield Hyperthermia Therapy for Cancer Product Portfolio
- 4.6.5 Thermofield Recent Developments
- 4.7 Celsius42
- 4.7.1 Celsius42 Company Information
- 4.7.2 Celsius42 Business Overview
- 4.7.3 Celsius42 Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Celsius42 Hyperthermia Therapy for Cancer Product Portfolio
- 4.7.5 Celsius42 Recent Developments
- 4.8 Dongseo Medicare
- 4.8.1 Dongseo Medicare Company Information
- 4.8.2 Dongseo Medicare Business Overview
- 4.8.3 Dongseo Medicare Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dongseo Medicare Hyperthermia Therapy for Cancer Product Portfolio
- 4.8.5 Dongseo Medicare Recent Developments
- 4.9 ThermaSolutions
- 4.9.1 ThermaSolutions Company Information
- 4.9.2 ThermaSolutions Business Overview
- 4.9.3 ThermaSolutions Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ThermaSolutions Hyperthermia Therapy for Cancer Product Portfolio
- 4.9.5 ThermaSolutions Recent Developments
- 4.10 Verthermia
- 4.10.1 Verthermia Company Information
- 4.10.2 Verthermia Business Overview
- 4.10.3 Verthermia Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Verthermia Hyperthermia Therapy for Cancer Product Portfolio
- 4.10.5 Verthermia Recent Developments
- 4.11 Combat Medical
- 4.11.1 Combat Medical Company Information
- 4.11.2 Combat Medical Business Overview
- 4.11.3 Combat Medical Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Combat Medical Hyperthermia Therapy for Cancer Product Portfolio
- 4.11.5 Combat Medical Recent Developments
- 4.12 Hydrosun
- 4.12.1 Hydrosun Company Information
- 4.12.2 Hydrosun Business Overview
- 4.12.3 Hydrosun Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hydrosun Hyperthermia Therapy for Cancer Product Portfolio
- 4.12.5 Hydrosun Recent Developments
- 4.13 RanD Biotech
- 4.13.1 RanD Biotech Company Information
- 4.13.2 RanD Biotech Business Overview
- 4.13.3 RanD Biotech Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 RanD Biotech Hyperthermia Therapy for Cancer Product Portfolio
- 4.13.5 RanD Biotech Recent Developments
- 4.14 Shenzhen ET Medical Technology
- 4.14.1 Shenzhen ET Medical Technology Company Information
- 4.14.2 Shenzhen ET Medical Technology Business Overview
- 4.14.3 Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Product Portfolio
- 4.14.5 Shenzhen ET Medical Technology Recent Developments
- 4.15 Jiangsu Nova Medical Equipment
- 4.15.1 Jiangsu Nova Medical Equipment Company Information
- 4.15.2 Jiangsu Nova Medical Equipment Business Overview
- 4.15.3 Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Product Portfolio
- 4.15.5 Jiangsu Nova Medical Equipment Recent Developments
5 Global Hyperthermia Therapy for Cancer Market Scenario by Region
- 5.1 Global Hyperthermia Therapy for Cancer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hyperthermia Therapy for Cancer Sales by Region: 2021-2032
- 5.2.1 Global Hyperthermia Therapy for Cancer Sales by Region: 2021-2026
- 5.2.2 Global Hyperthermia Therapy for Cancer Sales by Region: 2027-2032
- 5.3 Global Hyperthermia Therapy for Cancer Revenue by Region: 2021-2032
- 5.3.1 Global Hyperthermia Therapy for Cancer Revenue by Region: 2021-2026
- 5.3.2 Global Hyperthermia Therapy for Cancer Revenue by Region: 2027-2032
- 5.4 North America Hyperthermia Therapy for Cancer Market Facts & Figures by Country
- 5.4.1 North America Hyperthermia Therapy for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hyperthermia Therapy for Cancer Sales by Country (2021-2032)
- 5.4.3 North America Hyperthermia Therapy for Cancer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hyperthermia Therapy for Cancer Market Facts & Figures by Country
- 5.5.1 Europe Hyperthermia Therapy for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hyperthermia Therapy for Cancer Sales by Country (2021-2032)
- 5.5.3 Europe Hyperthermia Therapy for Cancer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hyperthermia Therapy for Cancer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hyperthermia Therapy for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hyperthermia Therapy for Cancer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hyperthermia Therapy for Cancer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hyperthermia Therapy for Cancer Market Facts & Figures by Country
- 5.7.1 South America Hyperthermia Therapy for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hyperthermia Therapy for Cancer Sales by Country (2021-2032)
- 5.7.3 South America Hyperthermia Therapy for Cancer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hyperthermia Therapy for Cancer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hyperthermia Therapy for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hyperthermia Therapy for Cancer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hyperthermia Therapy for Cancer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hyperthermia Therapy for Cancer Sales by Type (2021-2032)
- 6.1.1 Global Hyperthermia Therapy for Cancer Sales by Type (2021-2032) & (units)
- 6.1.2 Global Hyperthermia Therapy for Cancer Sales Market Share by Type (2021-2032)
- 6.2 Global Hyperthermia Therapy for Cancer Revenue by Type (2021-2032)
- 6.2.1 Global Hyperthermia Therapy for Cancer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hyperthermia Therapy for Cancer Revenue Market Share by Type (2021-2032)
- 6.3 Global Hyperthermia Therapy for Cancer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hyperthermia Therapy for Cancer Sales by Application (2021-2032)
- 7.1.1 Global Hyperthermia Therapy for Cancer Sales by Application (2021-2032) & (units)
- 7.1.2 Global Hyperthermia Therapy for Cancer Sales Market Share by Application (2021-2032)
- 7.2 Global Hyperthermia Therapy for Cancer Revenue by Application (2021-2032)
- 7.2.1 Global Hyperthermia Therapy for Cancer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hyperthermia Therapy for Cancer Revenue Market Share by Application (2021-2032)
- 7.3 Global Hyperthermia Therapy for Cancer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hyperthermia Therapy for Cancer Value Chain Analysis
- 8.1.1 Hyperthermia Therapy for Cancer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hyperthermia Therapy for Cancer Production Mode & Process
- 8.2 Hyperthermia Therapy for Cancer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hyperthermia Therapy for Cancer Distributors
- 8.2.3 Hyperthermia Therapy for Cancer Customers
9 Global Hyperthermia Therapy for Cancer Analyzing Market Dynamics
- 9.1 Hyperthermia Therapy for Cancer Industry Trends
- 9.2 Hyperthermia Therapy for Cancer Industry Drivers
- 9.3 Hyperthermia Therapy for Cancer Industry Opportunities and Challenges
- 9.4 Hyperthermia Therapy for Cancer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst